All News #Library
Others
DeepCure Launches STAT6 Inhibitor Program for Type 2 Inflammation
19 Dec 2024 //
BUSINESSWIRE
DeepCure Presents Ex Vivo Data For DC-9476 At ACR Convergence
24 Oct 2024 //
BUSINESSWIRE
DeepCure to Participate in Upcoming Investor Conferences
15 Oct 2024 //
BUSINESSWIRE
DeepCure: DC-9476 Tops Etanercept In Arthritis Study
03 Oct 2024 //
BUSINESSWIRE
DeepCure: Robotic Synthesis For Complex Testable Drug Molecules
28 May 2024 //
BUSINESSWIRE

Market Place
Sourcing Support